Tag: arthritis

FDA Approves Anifrolumab (Saphnelo) as New Lupus Treatment

Anifrolumab, an inhibitor of type 1 interferons, received approval from the Food and Drug Administration for the treatment of adults with moderate to severe systemic...

Rheumatologists’ Industry Payments Rise; Small Minority Gets Most

Practicing rheumatologists in the United States received more than $220 million from pharmaceutical companies during 2014-2019, with payments increasing each year, according to findings from...

Three New Drugs Implicated in ANCA-Associated Vasculitis

The overactive bladder treatment mirabegron (Myrbetriq) is one of three new drugs to be linked to cases of drug-associated antineutrophil cytoplasmic antibody–associated vasculitis (DA-AAV) according...

SLE Neuropsych Event Etiology Helps Define Predictors, Outcomes

Different kinds of neuropsychiatric (NP) events in patients with systemic lupus erythematosus (SLE) have substantial variability in their occurrence, resolution, and recurrence over time, as...

Wrist Fracture Outcomes Similar for Casting, Surgery

For older patients with distal radius wrist fractures, there are no significant differences in outcomes after 2 years when treated with nonsurgical casting compared with...

Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) issued an emergency use...

Are Medicare Beneficiaries With Knee Osteoarthritis Receiving Enough Conservative Care?

NEW YORK (Reuters Health) – Non-surgical care for knee osteoarthritis is uncommon among older adults, especially in regions of the U.S. where total knee arthroplasty...

Lupus Images Fall Short in Diversity

Lupus images in medical resource materials underrepresent patients with skin of color, based on data from a review of more than 1,400 images published between...

Tips to Help You Get Through the Day

The day-to-day demands of work can pose many challenges when you have arthritis. That’s true whether you work at a desk job or a job...

Studies Highlight Pandemic’s Impact on Patients With RMDs

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Reduced access to medical care, increased mental health issues, poor lifestyle...

IM, IA Steroid Injections Prove Noninferior in Knee OA

Intramuscular injections of glucocorticoids have efficacy similar to that of intra-articular injections in reducing pain in knee osteoarthritis but without the concerns about joint infection...

Fecal Transplantation Safe but Ineffective in PsA Trial

The first clinical trial of fecal microbiota transplantation in patients with psoriatic arthritis has found the procedure to be as safe as a sham procedure,...

Challenges Persist in Move to Adult Care for Rheumatic Diseases

The inadequacies and challenges of transitioning pediatric rheumatology patients to adult care were highlighted in several research studies shared at the annual scientific meeting of...

Veterinarian Helps Perform ‘Unproven’ Human Surgery

Millions Paid to Resolve Multiple Claims Involving “Unproven” Knee Surgery In what’s believed to be one of the largest public payouts in recent years, the...

Female Rheumatologists See Fewer Patients, Earn Less Than Males

A new study on the changing rheumatology workforce found that, although there has been a notable rise in female rheumatologists, they see fewer patients and...

Arthritis Drug May Curb Myocardial Damage in Acute STEMI

Early use of tocilizumab (Actemra) does not reduce myocardial infarct size but modestly increases myocardial salvage in patients with acute ST-segment elevation myocardial infarction (STEMI),...

Rheumatology Smoking Cessation Referral Program Finds Success

A new protocol designed to help patients in rheumatology clinics quit smoking proved both efficient and effective in referring willing participants to free tobacco quit...

Chronic Immune-Related Adverse Events Likely Common After Anti-PD-1 Therapy for Melanoma

NEW YORK (Reuters Health) – Chronic immune-related adverse events (irAEs) associated with anti-programmed cell death-1 (PD-1) therapy for melanoma were more common than previously thought...

Nearly 20% of Lupus Patients Have Severe Infection in First Decade After Diagnosis

People with systemic lupus erythematosus (SLE) experienced significantly higher rates of first severe infections, a higher number of severe infections overall, and greater infection-related mortality,...

RA Experts Highlight Key Developments Over the Past Year

A massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of lymphoma in patients with rheumatoid arthritis was hailed as one...

Rheumatoid Arthritis Meds May Help Fight Severe COVID

FRIDAY, Feb. 26, 2021 (HealthDay News) — Rheumatoid arthritis drugs may save lives of patients hospitalized with severe cases of COVID-19, according to a groundbreaking...

Tocilizumab May Improve Lung Function in Early Systemic Sclerosis

Treatment with tocilizumab (Actemra) could stabilize or improve lung function in people with early interstitial lung disease associated with systemic sclerosis (SSc-ILD), a new study...

Outcomes Have Improved for PAH in Connective Tissue Disease

Survival rates for patients with pulmonary arterial hypertension associated with connective tissue diseases have improved significantly in recent years, and there is growing evidence that...

‘Adaptive’ Yoga Opens This Practice to Everyone

Feb. 17, 2021 — The typical yoga class might look like a roomful of people bending and twisting themselves into various positions, but yoga is...

Accident Gives MS Doctor Insight Into Patients’ Lives

Editor’s note: The original text has been revised and updated. As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for...